CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts.
Autor: | Marangoni, E.1 Elisabetta.Marangoni@curie.fr, Lecomte, N.2, Durand, L.1, de Pinieux, G.3, Decaudin, D.1, Chomienne, C.2, Smadja-Joffe, F.2, Poupon, M.-F.1 |
---|---|
Zdroj: | British Journal of Cancer. 3/24/2009, Vol. 100 Issue 6, p918-922. 5p. 2 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |